BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32460232)

  • 1. Generation of three induced pluripotent stem cell (iPSC) lines from a multiple endocrine neoplasia type 1 (MEN1) patient and three iPSC lines from an unaffected relative of the patient.
    Yoshida S; Okura H; Suga H; Nishitomi T; Sakurai A; Arima H; Matsuyama A
    Stem Cell Res; 2020 Jul; 46():101846. PubMed ID: 32460232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of non-integrated induced pluripotent stem cells from a 23-year-old male with multiple endocrine neoplasia type 1 syndrome.
    Guo D; Wu F; Liu H; Gao G; Kou S; Yang F; Abbas N; Zhou T; Cai X; Zhang H; Qin D; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():70-72. PubMed ID: 28395810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome.
    Guo D; Wu F; Liu H; Gao G; Kou S; Yang F; Abbas N; Zhou T; Cai X; Zhang H; Qin D; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():64-66. PubMed ID: 28395808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN.
    Guo D; Liu H; Gao G; Liu Y; Zhuang Y; Yang F; Wang K; Zhou T; Qin D; Hong L; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():67-69. PubMed ID: 28395809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of four induced pluripotent stem cell lines (FHUi003-A, FHUi003-B, FHUi004-A and FHUi004-B) from two affected individuals of a familial neurohypophyseal diabetes insipidus family.
    Yoshida S; Okura H; Suga H; Soen M; Kawaguchi Y; Kurimoto J; Miyata T; Takagi H; Arima H; Fujikawa T; Otsuka F; Matsuyama A
    Stem Cell Res; 2020 Oct; 48():101960. PubMed ID: 32927425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of two spinal muscular atrophy (SMA) type I patient-derived induced pluripotent stem cell (iPSC) lines and two SMA type II patient-derived iPSC lines.
    Valetdinova KR; Maretina MA; Kuranova ML; Grigor'eva EV; Minina YM; Kizilova EA; Kiselev AV; Medvedev SP; Baranov VS; Zakian SM
    Stem Cell Res; 2019 Jan; 34():101376. PubMed ID: 30660867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Induced Pluripotent Stem Cell Characteristics Correlate with Efficient In Vitro Smooth Muscle Cell Differentiation? A Comparison of Three Patient-Derived Induced Pluripotent Stem Cell Lines.
    Zhou Y; Kang G; Wen Y; Briggs M; Sebastiano V; Pederson R; Chen B
    Stem Cells Dev; 2018 Oct; 27(20):1438-1448. PubMed ID: 30153084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of two iPSC lines (ICGi008-A and ICGi008-B) from skin fibroblasts of a patient with early-onset Alzheimer's disease caused by London familial APP mutation (V717I).
    Grigor'eva EV; Malankhanova TB; Ustyantseva EI; Minina JM; Redina OE; Morozov VV; Shevela AI; Zakian SM; Medvedev SP
    Stem Cell Res; 2019 Apr; 36():101415. PubMed ID: 30851551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and characterization of human induced pluripotent stem cells lines from four patients diagnosed with schizophrenia and one healthy control.
    Stock R; Vogel S; Mau-Holzmann UA; Kriebel M; Wüst R; Fallgatter AJ; Volkmer H
    Stem Cell Res; 2020 Oct; 48():101961. PubMed ID: 32911325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Induced Pluripotent Stem Cells from Lymphoblastoid Cell Lines by Electroporation of Episomal Vectors.
    Kim M; Park J; Kim S; Han DW; Shin B; Schöler HR; Kim J; Kim KP
    Int J Stem Cells; 2023 Feb; 16(1):36-43. PubMed ID: 36581370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of two induced pluripotent stem cell (iPSC) lines from human breast milk using episomal reprogramming system.
    Tang C; Lu C; Ji X; Ma L; Zhou Q; Xiong M; Zhou W
    Stem Cell Res; 2019 Aug; 39():101511. PubMed ID: 31404746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-integrating episomal vectors induced pluripotent stem cell line (SDPHi001-A) from a healthy female individual.
    Shao J; Shao C; Jin Y; Wang X; Fan H; Yang G
    Stem Cell Res; 2021 Oct; 56():102540. PubMed ID: 34547706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population.
    Malakhova AA; Grigor'eva EV; Pavlova SV; Malankhanova TB; Valetdinova KR; Vyatkin YV; Khabarova EA; Rzaev JA; Zakian SM; Medvedev SP
    Stem Cell Res; 2020 Oct; 48():101952. PubMed ID: 32805537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of induced pluripotent stem cell line ICGi018-A from peripheral blood mononuclear cells of a patient with Huntington's disease.
    Malakhova AA; Grigor'eva EV; Malankhanova TB; Pavlova SV; Valetdinova KR; Abramycheva NY; Vetchinova AS; Illarioshkin SN; Zakian SM
    Stem Cell Res; 2020 Apr; 44():101743. PubMed ID: 32179492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of control iPSC lines CBRCULi008-A and CBRCULi009-A derived from lymphoblastoid cell lines.
    Chapotte-Baldacci CA; Jauvin D; Chahine M
    Stem Cell Res; 2023 Sep; 71():103168. PubMed ID: 37473461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cell (iPSC) line (HEBHMUi002-A) from a healthy female individual and neural differentiation.
    Ma J; Zhang J; He J; Zhang Z; Li W; Feng B; Guo R; Amponsah AE; Kong D; Liu A; Song Y; Wei L; Cui H
    Stem Cell Res; 2020 Jan; 42():101669. PubMed ID: 31791011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an induced pluripotent stem cell line from a congenital microtia patient with 4p16.1 microduplication involving the long-range enhancer of HMX1.
    Si N; Zhang Z; Meng X; Huang X; Wang C; Pan B
    Stem Cell Res; 2021 May; 53():102357. PubMed ID: 34087987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.